Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-000995

Director sold 10,000 shares at $50.01 ($500,060)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Henderson Jeffrey William · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-01-06 Sale : show line 1 in the form 10b5-1 −10,000 $50.01 $500,060 43,611 D
Open-market sales · 10,000 sh · avg $50.01 · $500,060
Loading xslF345X05/form4-01072025_090159.xml…